|
Thrombosis and Hemostasis
Citations 51-60 of 126 total displayed.
|
Past content
(since Jan 2009):
|
Outcomes and predictors of very stable INR control during chronic anticoagulation therapy
- Daniel M. Witt, Thomas Delate, Nathan P. Clark, Chad Martell, Thu Tran, Mark A. Crowther, David A. Garcia, Walter Ageno, and Elaine M. Hylek, on behalf of the Warfarin Associated Research Projects and other EnDeavors (WARPED) Consortium
Blood 2009; 114: 952-956.
[Abstract]
[Full text]
[PDF]
Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer
- Raul Alba, Angela C. Bradshaw, Alan L. Parker, David Bhella, Simon N. Waddington, Stuart A. Nicklin, Nico van Rooijen, Jerome Custers, Jaap Goudsmit, Dan H. Barouch, John H. McVey, and Andrew H. Baker
Blood 2009; 114: 965-971.
[Abstract]
[Full text]
[PDF]
Endobrevin/VAMP-8–dependent dense granule release mediates thrombus formation in vivo
- Gwenda J. Graham, Qiansheng Ren, James R. Dilks, Price Blair, Sidney W. Whiteheart, and Robert Flaumenhaft
Blood 2009; 114: 1083-1090.
[Abstract]
[Full text]
[PDF]
A novel deletion mutation is recurrent in von Willebrand disease types 1 and 3
- Megan S. Sutherland, Anthony M. Cumming, Mackenzie Bowman, Paula H. B. Bolton-Maggs, Derrick J. Bowen, Peter W. Collins, Charles R. M. Hay, Andrew M. Will, and Stephen Keeney
Blood 2009; 114: 1091-1098.
[Abstract]
[Full text]
[PDF]
Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor?
- Tiziano Barbui, Alessandra Carobbio, Alessandro Rambaldi, and Guido Finazzi
Blood 2009; 114: 759-763.
[Abstract]
[Full text]
[PDF]
Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders
- Giuseppe Tagariello, Alfonso Iorio, Elena Santagostino, Massimo Morfini, Ruggero Bisson, Massimo Innocenti, Maria Elisa Mancuso, Maria Gabriella Mazzucconi, Gian Luigi Pasta, Paolo Radossi, Giuseppina Rodorigo, Cristina Santoro, Roberto Sartori, Antonio Scaraggi, Luigi Pier Solimeno, and Pier Mannuccio Mannucci, on behalf of the Italian Association Hemophilia Centre (AICE)
Blood 2009; 114: 779-784.
[Abstract]
[Full text]
[PDF]
Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A mice
- Mohammad Qadura, Braden Waters, Erin Burnett, Rouzbeh Chegeni, Scott Bradshaw, Christine Hough, Maha Othman, and David Lillicrap
Blood 2009; 114: 871-880.
[Abstract]
[Full text]
[PDF]
Dual role of collagen in factor XII–dependent thrombus formation
- Paola E. J. van der Meijden, Imke C. A. Munnix, Jocelyn M. Auger, José W. P. Govers-Riemslag, Judith M. E. M. Cosemans, Marijke J. E. Kuijpers, Henri M. Spronk, Steve P. Watson, Thomas Renné, and Johan W. M. Heemskerk
Blood 2009; 114: 881-890.
[Abstract]
[Full text]
[PDF]
Peripheral mural cell recruitment requires cell-autonomous heparan sulfate
- Denise Stenzel, Emma Nye, Maya Nisancioglu, Ralf H. Adams, Yu Yamaguchi, and Holger Gerhardt
Blood 2009; 114: 915-924.
[Abstract]
[Full text]
[PDF]
Correction of murine hemophilia A following nonmyeloablative transplantation of hematopoietic stem cells engineered to encode an enhanced human factor VIII variant using a safety-augmented retroviral vector
- Ali Ramezani and Robert G. Hawley
Blood 2009; 114: 526-534.
[Abstract]
[Full text]
[PDF]
|
|
